Chemfab Alkalis Ltd Stock Hits 52-Week Low at Rs.333

Stock Price Movement and Market Context

On 11 Mar 2026, Chemfab Alkalis Ltd’s shares opened sharply lower with a gap down of -8.34%, hitting an intraday low of Rs.333, the lowest level in the past year. Despite this, the stock managed to recover somewhat during the session, reaching an intraday high of Rs.385.3, a 6.06% rise from the day’s low, and outperformed its sector by 4.6%. The stock’s price currently sits above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a prevailing bearish trend in the medium to long term.

The broader market context has also been unfavourable. The Sensex, after a flat opening, declined by 668.71 points or -0.81% to close at 77,570.20, continuing its three-week losing streak with a cumulative fall of -6.33%. The index is trading below its 50-day moving average, which itself is below the 200-day moving average, signalling a bearish market environment. While some indices such as NIFTY MIDCAP150 and NIFTY SMALLCAP250 hit new 52-week highs today, Chemfab Alkalis Ltd’s performance starkly contrasts with these gains.

Financial Performance and Valuation Concerns

Chemfab Alkalis Ltd’s financial metrics reveal ongoing difficulties. The company has reported negative results for 11 consecutive quarters, with net sales in the most recent quarter at Rs.68.14 crores, down by 20.8% compared to the previous four-quarter average. Operating profit to interest ratio has deteriorated to a low of 0.96 times, reflecting limited coverage of interest expenses by operating earnings. The company posted a net loss (PAT) of Rs.4.45 crores in the latest quarter, a steep decline of 670.5% relative to the prior four-quarter average.

Over the last five years, operating profit has contracted at an annualised rate of -28.88%, underscoring the company’s struggles to generate sustainable growth. Return on capital employed (ROCE) stands at a modest 1.8%, while the enterprise value to capital employed ratio is 1.3, suggesting an expensive valuation relative to the company’s capital base. Despite this, the stock trades at a discount compared to its peers’ historical valuations, reflecting the market’s cautious stance.

Stock Performance Relative to Benchmarks

Over the past year, Chemfab Alkalis Ltd’s stock has declined by 49.11%, significantly underperforming the Sensex, which gained 4.69% during the same period. The stock has also lagged behind the BSE500 index over the last three years, one year, and three months, highlighting a consistent underperformance trend. This weak price performance aligns with the company’s deteriorating profitability and subdued growth prospects.

Despite the company’s size, domestic mutual funds hold a minimal stake of just 0.25%, which may reflect limited confidence in the stock’s near-term prospects or valuation. The company’s debt to equity ratio remains low at an average of 0.10 times, indicating a conservative capital structure with limited leverage.

Technical Indicators and Market Sentiment

Technical analysis presents a mixed picture. On a weekly basis, the Moving Average Convergence Divergence (MACD) and Know Sure Thing (KST) indicators show mild bullish signals, while monthly readings for both are bearish. The Relative Strength Index (RSI) offers no clear signals on either timeframe. Bollinger Bands indicate bearish trends on both weekly and monthly charts, and daily moving averages remain bearish. Dow Theory analysis shows no clear trend weekly but mildly bearish monthly signals. On-balance volume (OBV) is neutral weekly but bullish monthly, suggesting some accumulation over the longer term despite recent price weakness.

Rating and Market Perception

MarketsMOJO assigns Chemfab Alkalis Ltd a Mojo Score of 26.0, categorising it as a Strong Sell. This rating was downgraded from Sell on 7 Jul 2025, reflecting a deterioration in the company’s fundamentals and outlook. The market capitalisation grade stands at 4, indicating a relatively modest size within its sector. The stock’s recent day change was a positive 4.36%, following two consecutive days of decline, but this short-term gain has not altered the broader negative trend.

The company’s commodity chemicals sector peers generally trade at higher valuations and have demonstrated more stable financial performance, which contrasts with Chemfab Alkalis Ltd’s ongoing challenges. The stock’s 52-week high was Rs.900, underscoring the extent of the decline to the current low of Rs.333.

Summary of Key Financial Metrics

Net sales for the latest quarter stood at Rs.68.14 crores, down 20.8% from the previous four-quarter average. Operating profit to interest coverage ratio is at a low 0.96 times, indicating tight earnings relative to interest obligations. The company reported a net loss of Rs.4.45 crores, a decline of 670.5% compared to the prior four-quarter average. ROCE is 1.8%, and the enterprise value to capital employed ratio is 1.3, suggesting valuation concerns despite the discounted stock price.

Over the past year, profits have fallen by 141.9%, while the stock price has declined by 49.11%, reflecting the company’s financial stress and market sentiment.

Conclusion

Chemfab Alkalis Ltd’s stock reaching a 52-week low of Rs.333 highlights the ongoing difficulties faced by the company in terms of financial performance and market valuation. The combination of declining sales, persistent losses, and subdued profitability metrics has weighed heavily on the stock price. Technical indicators and market trends suggest a cautious environment, with limited signs of sustained recovery in the near term. The company’s low debt levels provide some balance to its financial profile, but the overall picture remains challenging within the commodity chemicals sector.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →